Department of Biomedical Engineering, Rutgers University, Piscataway, NJ 08854, USA.
Department of Physics, East Carolina University, Greenville, NC 27858, USA.
Biomolecules. 2024 Feb 16;14(2):230. doi: 10.3390/biom14020230.
Altered properties of fibrin clots have been associated with bleeding and thrombotic disorders, including hemophilia or trauma and heart attack or stroke. Clotting factors, such as thrombin and tissue factor, or blood plasma proteins, such as fibrinogen, play critical roles in fibrin network polymerization. The concentrations and combinations of these proteins affect the structure and stability of clots, which can lead to downstream complications. The present work includes clots made from plasma and purified fibrinogen and shows how varying fibrinogen and activation factor concentrations affect the fibrin properties under both conditions. We used a combination of scanning electron microscopy, confocal microscopy, and turbidimetry to analyze clot/fiber structure and polymerization. We quantified the structural and polymerization features and found similar trends with increasing/decreasing fibrinogen and thrombin concentrations for both purified fibrinogen and plasma clots. Using our compiled results, we were able to generate multiple linear regressions that predict structural and polymerization features using various fibrinogen and clotting agent concentrations. This study provides an analysis of structural and polymerization features of clots made with purified fibrinogen or plasma at various fibrinogen and clotting agent concentrations. Our results could be utilized to aid in interpreting results, designing future experiments, or developing relevant mathematical models.
纤维蛋白凝块的性质改变与出血和血栓形成障碍有关,包括血友病或创伤、心脏病发作或中风。凝血因子,如凝血酶和组织因子,或血浆蛋白,如纤维蛋白原,在纤维蛋白网络聚合中发挥关键作用。这些蛋白质的浓度和组合影响血栓的结构和稳定性,从而导致下游并发症。本工作包括由血浆和纯化纤维蛋白原制成的凝块,并展示了纤维蛋白原和激活因子浓度的变化如何在两种情况下影响纤维蛋白的性质。我们使用扫描电子显微镜、共聚焦显微镜和比浊法来分析凝块/纤维结构和聚合。我们量化了结构和聚合特征,并发现随着纯化纤维蛋白原和血浆凝块中纤维蛋白原和凝血酶浓度的增加/减少,出现了相似的趋势。利用我们汇编的结果,我们能够生成多元线性回归,使用各种纤维蛋白原和凝血剂浓度预测结构和聚合特征。本研究分析了用不同纤维蛋白原和凝血剂浓度的纯化纤维蛋白原或血浆制成的凝块的结构和聚合特征。我们的结果可用于辅助解释结果、设计未来实验或开发相关的数学模型。